Department of Medicine Archive — Page 87 of 127

From left, Alexander Gelbard, MD, Suman Das, PhD, and Simon Mallal, MBBS, are among a team of researchers searching for the cause of a rare airway disease that almost exclusively affects adult, Caucasian women.
June 13, 2019

Study seeks to expand treatment options for rare airway disease

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.

Illustrated gray molar covered with colorful bacteria- and virus-like forms, representing oral infection and dental hygiene.
June 6, 2019

Mouth microbes and colorectal cancer

Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC.

Sara Van Driest, MD, PhD, with Dan Roden, MD, who nominated her for the award from the American Society of Clinical Pharmacology and Therapeutics.
May 22, 2019

Van Driest lands young investigator award from the American Society for Clinical Pharmacology and Therapeutics

Sara Van Driest, MD, PhD, assistant professor of Pediatrics and Medicine, recently received the 2019 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics.

White wireframe illustration of a human heart on a blue architectural blueprint grid.
May 9, 2019

Blueprint for rebuilding the heart

Young-Jae Nam and colleagues are discovering how to express specific factors in connective tissue cells to turn them into heart muscle cells.

Portrait of a bespectacled man in a dark jacket and checked shirt outdoors.
May 2, 2019

Wilson appointed to ASGCT board of directors

The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as an at-large director.

Medical illustration of the stomach and intestines, with the stomach highlighted in red and an enlarged bacterium-like form shown inside it.
April 25, 2019

Receptor’s role in stopping H. pylori

The immune receptor NOD1 may be a prime target for preventing or treating H. pylori infections — the most significant risk factor for stomach cancer, Vanderbilt researchers have discovered.